Please assess the completion status of the following clinical trial:

Trial Title: Embryo Selection by Time Lapse Monitoring for Single Embryo Transfer (SET)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age \< 36 yrs~* baseline FSH \<10 IU/l~* regular 25-35 day cycles~* less than 2 previous failed IVF cycles~* intact uterus~* an indication for IVF~* BMI \<18- \<30 kg/m2~* acceptance of single embryo transfer~Exclusion Criteria:~* PCOS~* Sperm obtained by surgical extraction~* chromosome abnormality~* Presence of hydrosalpinx~* stage III/IV endometriosis~* Less than 3 good quality day 3 embryos~* only one good quality day 5 embryos~* lack of consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 36 Years
- Healthy Volunteers: t

Study Arms:
- time-lapse morphokinetic evaluation (Type: EXPERIMENTAL): Embryo selection for transfer based on a combind score made up of scores for kinetic parameters and standard morphology as seen on time-lapse: upon fertilization embryos in a petri dish that allows individual assessment (Primo Vision Dish) are placed onto an automated time-lapse equipment in an incubator. The time-lapse equipment performs imaging in 10 minutes intervals. The software is presenting the up-to-date images and allows the operator to assess the time-lapse movie of the developmental history of the embryos to perform annotations and apply evaluation/selection algorithm. This morpho-kinetic TL algorithm (made up of standard moprhology as seen on time lapse and kinetci scores) is used for embryo selection, which actually describes the intervention.
- standard embryo monitoring (Type: NO_INTERVENTION): Upon fertilization embryos are observed once on days 1-3-5 by the embryologist to check for development. The single embryo for transfer is selected based on actual morphology as seen under light microscope.

Based on this trial design, predict the completion outcome and termination type (if applicable).